Ventipulmin for Horses - Syrup 330ml - [Respiratory Disease Treatment]

Ventipulmin Syrup is a treatment for acute and chronic respiratory disease where airway obstruction due to bronchospasm and/or mucus accumulation is a contributing factor and improved mucociliary clearance is desirable. To be used alone or as adjunctive therapy in Chronic Obstructive Pulmonary Disease (COPD). Acute, sub-acute and chronic respiratory allergic conditions.

Key Benefits

• Provides relief of the airways
• Helps your horse breathe easier
• Manages symptoms of airway obstruction conditions like COPD
• Tasty syrup for easy administration

How It Works

Ventipulmin Syrup contains the active ingredient, Clenbuterol HCl, which quickly reaches lung tissue concentration to provide relief. The syrup causes smooth muscles in the airway to relax, allowing for bronchodilation, which helps decrease resistance in the respiratory pathway and increase airflow to the lungs. Ventipulmin Syrup also decreases the thickness of mucus to help improve respiratory airflow.

Indications

Ventipulmin Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).

Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.

• Initial dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments)
• If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments)
• If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments)
• If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments)
• If no improvement, horse is non-responsive to clenbuterol and treatment should be discontinued.
• Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.

Remove safety cap and seal; replace with enclosed plastic dispensing cap. Remove cover from dispensing tip and connect syringe (without needle). Draw out appropriate volume of Ventipulmin Syrup. Administer orally to the horse. Replace cover on dispensing tip to prevent leakage.

Administer two treatments per day.

Caution:

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this drug in food animals.

Contraindications:

Ventipulmin Syrup antagonizes the effects of prostaglandin F2 alpha and oxytocin. Ventipulmin Syrup should not be used in pregnant mares near term. Because tachycardia may occur, Ventipulmin Syrup should not be used in horses suspected of having cardiovascular impairment.

Warning:

The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.

Human Warning:

Not for human use. Do not use in horses intended for human consumption. Keep out of the reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of Ventipulmin Syrup may cause undesirable reactions. Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.

Precaution:

The safety cap should be placed on the bottle when not in use.

Adverse Reactions:

Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse reactions, to obtain a Material Safety Data Sheet (MSDS), or for technical assistance, call 1-866-638-2226.

Storage:

Store at or below 25°C (77°F). Avoid freezing.